載入中
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
前收盤價
US$6.54
+US$0.035 · +0.54%
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
日內區間
目前US$6.54
52週區間
目前US$6.54
盤中時間採用ET。市場資料可能有所延遲。
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
日內區間
目前US$6.54
52週區間
目前US$6.54
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2124.86萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM946.29萬0.01%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF812.51萬0.01%954億 USD0.05%US$235+0.80%
State Street SPDR S&P Biotech ETFXBI618.51萬0.06%98.74億 USD0.35%US$153.77+3.00%
iShares Biotechnology ETFIBB335.34萬0.03%108.2億 USD0.44%US$206.49+3.00%
iShares Russell 2000 Growth ETFIWO324.3萬0.02%139.17億 USD0.24%US$356.78+0.94%
Dimensional - US Small Cap ETFDFAS217.8萬0.01%338.69億 USD0.31%US$78.35+0.32%
Fidelity Enhanced Small Cap ETFFESM215.3萬0.03%64.1億 USD0.28%US$45.46+0.46%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFState Street SPDR S&P Biotech ETFXBIiShares Biotechnology ETFIBBiShares Russell 2000 Growth ETFIWODimensional - US Small Cap ETFDFASFidelity Enhanced Small Cap ETFFESMAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
